Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity
Abstract Background Dengue virus (DENV) nonstructural protein 1 (NS1) has multiple functions within infected cells, on the cell surface, and in secreted form, and is highly immunogenic. Immunity from previous DENV infections is known to exert both positive and negative effects on subsequent DENV inf...
Saved in:
Published in | The Journal of infectious diseases Vol. 230; no. 5; pp. 1147 - 1156 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
15.11.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Background
Dengue virus (DENV) nonstructural protein 1 (NS1) has multiple functions within infected cells, on the cell surface, and in secreted form, and is highly immunogenic. Immunity from previous DENV infections is known to exert both positive and negative effects on subsequent DENV infections, but the contribution of NS1-specific antibodies to these effects is incompletely understood.
Methods
We investigated the functions of NS1-specific antibodies and their significance in DENV infection. We analyzed plasma samples collected in a prospective cohort study prior to symptomatic or subclinical secondary DENV infection. We measured binding to purified recombinant NS1 protein and to NS1-expressing CEM cells, antibody-mediated natural killer (NK) cell activation by plate-bound NS1 protein, and antibody-dependent cellular cytotoxicity (ADCC) of NS1-expressing target cells.
Results
We found that antibody responses to NS1 were highly serotype cross-reactive and that subjects who experienced subclinical DENV infection had significantly higher antibody responses to NS1 in preinfection plasma than subjects who experienced symptomatic infection. We observed strong positive correlations between antibody binding and NK activation.
Conclusions
These findings demonstrate the involvement of NS1-specific antibodies in ADCC and provide evidence for a protective effect of NS1-specific antibodies in secondary DENV infection.
Antibodies to dengue virus NS1 protein activated NK cells and mediated antibody-dependent cellular cytotoxicity. Higher preexposure antibody responses to NS1 in cohort subjects who experienced subclinical compared to symptomatic dengue virus infections point to a protective role against illness. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Potential conflicts of interest. A. F. received support for conference registration and travel from Janssen Pharmaceuticals. K. A. received payments for service on a Data and Safety Monitoring Board from AstraZeneca and an advisory board from Emergent Biosolutions. J. C. is coinventor on a patent for “IgA Monoclonal Antibodies for Treating Flavivirus Infection”. A. L. R. received payments from Takeda (consulting and Advisory Board) and Moderna (consulting); and support for travel from Takeda. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. |
ISSN: | 0022-1899 1537-6613 1537-6613 |
DOI: | 10.1093/infdis/jiae137 |